Intrathecal baclofen as an effective treatment for generalized dystonia in Wilson's disease
- PMID: 37733332
- PMCID: PMC10664811
- DOI: 10.23736/S1973-9087.23.07960-1
Intrathecal baclofen as an effective treatment for generalized dystonia in Wilson's disease
Conflict of interest statement
Similar articles
-
Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A.Arq Neuropsiquiatr. 2012 Jun;70(6):407-9. doi: 10.1590/s0004-282x2012000600005. Arq Neuropsiquiatr. 2012. PMID: 22699536
-
Cannabis sativa and dystonia secondary to Wilson's disease.Mov Disord. 2005 Jan;20(1):113-5. doi: 10.1002/mds.20268. Mov Disord. 2005. PMID: 15390041
-
Gabapentin can improve dystonia in confirmed Wilson disease.Can J Neurol Sci. 2014 Mar;41(2):284-5. doi: 10.1017/s0317167100016759. Can J Neurol Sci. 2014. PMID: 24534048 No abstract available.
-
Recognition and treatment of neurologic Wilson's disease.Semin Neurol. 2012 Nov;32(5):538-43. doi: 10.1055/s-0033-1334476. Epub 2013 May 15. Semin Neurol. 2012. PMID: 23677665 Review.
-
Intrathecal baclofen in the treatment of post-stroke central pain, dystonia, and persistent vegetative state.Acta Neurochir Suppl. 2007;97(Pt 1):227-9. doi: 10.1007/978-3-211-33079-1_31. Acta Neurochir Suppl. 2007. PMID: 17691381 Review.
Cited by
-
Intrathecal Baclofen Therapy Improves Refractory Status Dystonicus in Neuro-hepatic Wilson's Disease: A Case Report.NMC Case Rep J. 2025 Apr 1;12:91-95. doi: 10.2176/jns-nmc.2024-0234. eCollection 2025. NMC Case Rep J. 2025. PMID: 40255925 Free PMC article.
References
-
- Biering-Soerensen B, Stevenson V, Bensmail D, Grabljevec K, Martínez Moreno M, Pucks-Faes E, et al. European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A. J Rehabil Med 2022;54:jrm00241. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&l... - PMC - PubMed
-
- Bonouvrié LA, Becher JG, Vles JS, Vermeulen RJ, Buizer AI, IDYS Study Group . The Effect of Intrathecal Baclofen in Dyskinetic Cerebral Palsy: the IDYS Trial. Ann Neurol 2019;86:79–90. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&l... 10.1002/ana.25498 - DOI - PMC - PubMed
-
- Ford B, Greene P, Louis ED, Petzinger G, Bressman SB, Goodman R, et al. Use of intrathecal baclofen in the treatment of patients with dystonia. Arch Neurol 1996;53:1241–6. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&l... 10.1001/archneur.1996.00550120049016 - DOI - PubMed
-
- Meythaler JM, Guin-Renfroe S, Hadley MN. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report. Am J Phys Med Rehabil 1999;78:247–54. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&l... 10.1097/00002060-199905000-00012 - DOI - PubMed
-
- van Hilten BJ, van de Beek WJ, Hoff JI, Voormolen JH, Delhaas EM. Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med 2000;343:625–30. https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&l... 10.1056/NEJM200008313430905 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical